Changing the paradigm in the treatment of platinum-sensitive recurrent ovarian cancer: from platinum doublets to nonplatinum doublets and adding antiangiogenesis compounds.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Volumn 19 Suppl 2, Issue , 2009, Pages

  Monk, Bradley J ^a   Coleman, Robert L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; PLATINUM DERIVATIVE;

ALGORITHM; CARCINOMA; DRUG EFFECT; DRUG RESISTANCE; EVALUATION; FEMALE; GYNECOLOGY; HUMAN; METHODOLOGY; ONCOLOGY; OVARY TUMOR; PATHOLOGY; RECURRENT DISEASE; REVIEW;

ALGORITHMS; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; DRUG RESISTANCE, NEOPLASM; FEMALE; GYNECOLOGY; HUMANS; MEDICAL ONCOLOGY; OVARIAN NEOPLASMS; PLATINUM COMPOUNDS; RECURRENCE;

MLCS; MLOWN;

EID: 77950349922     PISSN: None     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/igc.0b013e3181c104fa     Document Type: Review

References (22)